Liensinine alleviates high fat diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD) through suppressing oxidative stress and inflammation via regulating TAK1/AMPK signaling

International Immunopharmacology(2022)

引用 19|浏览3
暂无评分
摘要
•Liensinine reduces lipid deposition and ROS produce in PA-incubated cells.•Liensinine mitigates inflammatory response in PA-stimulated cells.•Liensinine ameliorates NAFLD pathologies in HFD-fed mice.•Liensinine reduces lipid accumulation in liver of HFD-challenged mice.
更多
查看译文
关键词
NAFLD,Liensinine (LIEN),Lipid deposition,Oxidative stress and inflammation,TAK1/AMPK
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要